Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Paediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.

A visualisation showing a map with number of COVID-19 cases around the world

Maria Cobo, a DPhil student with the Paediatric Neuroimaging Group, is part of the Open COVID-19 Data Working Group, a response project coordinated by the Department of Zoology and the Oxford Martin School. It is an international team of volunteers curating data sources by hand and compiling the data in a standardised format. Uniquely, this format presents epidemiological data at an individual case level, which allows the extraction of detailed information on case demographics, travel histories and high resolution geographical distribution.

The cumulative results are updated daily, and can be viewed here: https://www.healthmap.org/covid-19/

Data fuelling the project are openly accessible here: https://github.com/beoutbreakprepared/nCoV2019/tree/master/latest_data

The description of the database and methods used was recently published in Scientific Data.

If you would like to take part in the project, please get in touch with Maria Cobo.

 

Funding for Oxford’s COVID-19 research requires unprecedented speed, scope and ambition. If you would like to support this work, please make a gift  >>

Similar stories

Oxford vaccine professor: rich countries have a moral duty to share their COVID-19 shots

COVID-19 Vaccinology

Andrew Pollard writes about vaccine equity in his article for The Conversation.

Increasing vaccine uptake among ethnic minorities

COVID-19 Public Engagement Vaccinology

Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.

Why we must expand newborn screening

Neuromuscular Diseases Research

Early diagnosis is of primary importance both to obtain the best effect of innovative medications and to accelerate their development, writes Professor Laurent Servais.

Human challenge trial launches to study immune response to COVID-19

COVID-19 Vaccinology

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

COVID-19 Clinical Trials Vaccinology

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

COVID-19 Vaccinology

Medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.